Skip to content
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals
  • Investors & Media
  • Contact Us
  • Investors & Media
  • Contact Us
Ironwood Pharmaceuticals Logo
Ironwood Pharmaceuticals
Close
  • Company
    • Company Overview
    • Leadership
    • Open Payments & Transparency
  • Science & Medicine
    • Therapeutic Focus
    • Pipeline
    • Product
  • Patients
    • Overview
  • Responsibility
    • Overview
    • Diversity, Equity & Inclusion
    • Sustainability
    • Safety & Compliance
    • Patients & Research
    • Community Giving
  • Careers
    • Working at Ironwood
    • Internships, Co-ops
      and Fellowships
    • Open Positions
  • Company
    • Company Overview
    • Leadership
    • Open Payments & Transparency
  • Science & Medicine
    • Therapeutic Focus
    • Pipeline
    • Product
  • Patients
    • Overview
  • Responsibility
    • Overview
    • Diversity, Equity & Inclusion
    • Sustainability
    • Safety & Compliance
    • Patients & Research
    • Community Giving
  • Careers
    • Working at Ironwood
    • Internships, Co-ops
      and Fellowships
    • Open Positions

Category: Uncategorized

Ironwood Pharmaceuticals Announces Intent to Separate Soluble Guanylate Cyclase (sGC) Business from Commercial and Gastrointestinal Business

https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-Announces-Intent-to-Separate-Soluble-Guanylate-Cyclase-sGC-Business-from-Commercial-and-Gastrointestinal-Business/default.aspx

Ironwood Pharmaceuticals Provides First Quarter 2018 Investor Update

https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-Provides-First-Quarter-2018-Investor-Update/default.aspx

Allergan and Ironwood Launch Interactive Digital Destination During Irritable Bowel Syndrome (IBS) Awareness Month Designed to Encourage Sufferers to Get Educated and Take Action

https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Allergan-and-Ironwood-Launch-Interactive-Digital-Destination-During-Irritable-Bowel-Syndrome-IBS-Awareness-Month-Designed-to-Encourage-Sufferers-to-Get-Educated-and-Take-Action/default.aspx

Ironwood Pharmaceuticals Announces Intent to Separate Soluble Guanylate Cyclase (sGC) Business from Commercial and Gastrointestinal Business

https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-Announces-Intent-to-Separate-Soluble-Guanylate-Cyclase-sGC-Business-from-Commercial-and-Gastrointestinal-Business/default.aspx

Ironwood Pharmaceuticals Provides First Quarter 2018 Investor Update

https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-Provides-First-Quarter-2018-Investor-Update/default.aspx

Allergan and Ironwood Launch Interactive Digital Destination During Irritable Bowel Syndrome (IBS) Awareness Month Designed to Encourage Sufferers to Get Educated and Take Action

https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Allergan-and-Ironwood-Launch-Interactive-Digital-Destination-During-Irritable-Bowel-Syndrome-IBS-Awareness-Month-Designed-to-Encourage-Sufferers-to-Get-Educated-and-Take-Action/default.aspx

Ironwood Pharmaceuticals to Host First Quarter 2018 Investor Update Call

https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-to-Host-First-Quarter-2018-Investor-Update-Call/default.aspx

Ironwood Pharmaceuticals to Host First Quarter 2018 Investor Update Call

https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-to-Host-First-Quarter-2018-Investor-Update-Call/default.aspx

Ironwood Pharmaceuticals Announces Director Nomination from Sarissa Capital

https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-Announces-Director-Nomination-from-Sarissa-Capital/default.aspx

Ironwood Pharmaceuticals Announces Director Nomination from Sarissa Capital

https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-Announces-Director-Nomination-from-Sarissa-Capital/default.aspx

← Previous
Next →
Ironwood Pharmaceuticals Home
  • Investors & Media
  • Contact Us
Linkedin Twitter
  • Company
    • Company Overview
    • Leadership
    • Open Payments & Transparency
  • Science & Medicine
    • Therapeutic Focus
    • Pipeline
    • Product
  • Patients
    • Overview
  • Responsibility
    • Overview
    • Diversity, Equity & Inclusion
    • Sustainability
    • Safety & Compliance
    • Patients & Research
    • Community Giving
  • Careers
    • Working at Ironwood
    • Internships, Co-ops
      and Fellowships
    • Open Positions
  • Copyright © 2024 Ironwood. All rights reserved
  • Privacy Policy
  • Terms of Use
  • Company
    • Company Overview
    • Leadership
    • Open Payments & Transparency
  • Science & Medicine
    • Therapeutic Focus
    • Pipeline
    • Product
  • Patients
    • Overview
  • Responsibility
    • Overview
    • Diversity, Equity & Inclusion
    • Sustainability
    • Safety & Compliance
    • Patients & Research
    • Community Giving
  • Careers
    • Working at Ironwood
    • Internships, Co-ops
      and Fellowships
    • Open Positions
    • Investors & Media
    • Contact Us